Literature DB >> 33613625

Identification of Regulatory circRNAs Involved in the Pathogenesis of Acute Myocardial Infarction.

Cuimei Zhao1, Jingjing Liu2, Wen Ge3, Zhi Li4, Mengwei Lv5,6, Yipeng Feng7, Xuebo Liu1, Ban Liu8, Yangyang Zhang5,6.   

Abstract

BACKGROUND: Acute myocardial infarction (AMI) has high morbidity and mortality worldwide. However, the pathogenesis of AMI is still unclear, and the impact of circular RNAs (circRNAs) on AMI has rarely been recognized and needs to be explored.
MATERIALS AND METHODS: The circRNA array was applied to investigate the expression level of circRNAs in the blood samples of coronary arteries of three AMI patients and three normal persons. Principal component analysis (PCA) and unsupervised clustering analysis were performed to reveal the distinguished expression patterns of circRNAs. The miRNA expression profiles of AMI patients were identified from a public dataset from the Gene Expression Omnibus (GEO) database (GSE31568). The miRNA binding sites on the circRNAs were predicted by miRanda. The miRNA enrichment analysis and annotation tool were used to explore the pathways that the dysregulated circRNAs may participate in.
RESULTS: In total, 142 differentially expressed circRNAs, including 89 upregulated and 53 downregulated in AMI samples, were identified by the differential expression analysis. AMI patients had quite different circRNA expression profiles to those of normal controls. Functional characterization revealed that circRNAs that had the potential to regulate miRNAs were mainly involved in seven pathways, such as the Runt-related transcription factor-1 (RUNX1) expression and activity-related pathway. Specifically, hsa_circRNA_001654, hsa_circRNA_091761, hsa_circRNA_405624, and hsa_circRNA_406698 were predicted to sponge four miRNAs including hsa-miR-491-3p, hsa-miR-646, hsa-miR-603, and hsa-miR-922, thereby regulating RUNX1 expression or activity.
CONCLUSION: We identified dysregulated blood circRNAs in the coronary arteries of AMI patients and predicted that four upregulated circRNAs were involved in the regulation of RUNX1 expression or activity through sponging four miRNAs.
Copyright © 2021 Zhao, Liu, Ge, Li, Lv, Feng, Liu, Liu and Zhang.

Entities:  

Keywords:  acute myocardial infarction; circRNA; functional characterization; miRNA; runt-related transcription factor-1

Year:  2021        PMID: 33613625      PMCID: PMC7886988          DOI: 10.3389/fgene.2020.626492

Source DB:  PubMed          Journal:  Front Genet        ISSN: 1664-8021            Impact factor:   4.599


  27 in total

Review 1.  MicroRNAs: genomics, biogenesis, mechanism, and function.

Authors:  David P Bartel
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

2.  Myocardial Infarction-Associated Circular RNA Predicting Left Ventricular Dysfunction.

Authors:  Melanie Vausort; Antonio Salgado-Somoza; Lu Zhang; Przemyslaw Leszek; Markus Scholz; Andrej Teren; Ralph Burkhardt; Joachim Thiery; Daniel R Wagner; Yvan Devaux
Journal:  J Am Coll Cardiol       Date:  2016-09-13       Impact factor: 24.094

3.  Oncostatin M is a major mediator of cardiomyocyte dedifferentiation and remodeling.

Authors:  Thomas Kubin; Jochen Pöling; Sawa Kostin; Praveen Gajawada; Stefan Hein; Wolfgang Rees; Astrid Wietelmann; Minoru Tanaka; Holger Lörchner; Silvia Schimanski; Marten Szibor; Henning Warnecke; Thomas Braun
Journal:  Cell Stem Cell       Date:  2011-11-04       Impact factor: 24.633

Review 4.  Notch signaling as an important mediator of cardiac repair and regeneration after myocardial infarction.

Authors:  Yuxin Li; Yukio Hiroi; James K Liao
Journal:  Trends Cardiovasc Med       Date:  2010-10       Impact factor: 6.677

Review 5.  CircRNA: a novel type of biomarker for cancer.

Authors:  He-da Zhang; Lin-Hong Jiang; Da-Wei Sun; Jun-Chen Hou; Zhen-Ling Ji
Journal:  Breast Cancer       Date:  2017-07-18       Impact factor: 4.239

6.  Transcription Factor RUNX1 Regulates Platelet PCTP (Phosphatidylcholine Transfer Protein): Implications for Cardiovascular Events: Differential Effects of RUNX1 Variants.

Authors:  Guangfen Mao; Natthapol Songdej; Deepak Voora; Lawrence E Goldfinger; Fabiola E Del Carpio-Cano; Rachel A Myers; A Koneti Rao
Journal:  Circulation       Date:  2017-07-04       Impact factor: 29.690

Review 7.  Circular RNAs open a new chapter in cardiovascular biology.

Authors:  Simona Aufiero; Yolan J Reckman; Yigal M Pinto; Esther E Creemers
Journal:  Nat Rev Cardiol       Date:  2019-08       Impact factor: 32.419

Review 8.  Regulatory Roles of Circular RNAs in Coronary Artery Disease.

Authors:  Shuchen Zhang; Wenjing Wang; Xiaoguang Wu; Xiang Zhou
Journal:  Mol Ther Nucleic Acids       Date:  2020-05-23       Impact factor: 8.886

9.  Expression Profiles and Ontology Analysis of Circular RNAs in a Mouse Model of Myocardial Ischemia/Reperfusion Injury.

Authors:  Zhaoqing Sun; Tongtong Yu; Yundi Jiao; Dongxu He; Jiake Wu; Weili Duan; Zhijun Sun
Journal:  Biomed Res Int       Date:  2020-05-20       Impact factor: 3.411

10.  RUNX1: an emerging therapeutic target for cardiovascular disease.

Authors:  Alexandra Riddell; Martin McBride; Thomas Braun; Stuart A Nicklin; Ewan Cameron; Christopher M Loughrey; Tamara P Martin
Journal:  Cardiovasc Res       Date:  2020-07-01       Impact factor: 10.787

View more
  4 in total

Review 1.  Extracellular Circular RNAs Act as Novel First Messengers Mediating Cell Cross-Talk in Ischemic Cardiac Injury and Myocardial Remodeling.

Authors:  Mengyang Li; Wei Ding; Gaoli Liu; Jianxun Wang
Journal:  J Cardiovasc Transl Res       Date:  2022-02-19       Impact factor: 3.216

Review 2.  The circRNA-miRNA/RBP regulatory network in myocardial infarction.

Authors:  Lei Zhang; Yuan Zhang; Fei Yu; Xin Li; Huijuan Gao; Peifeng Li
Journal:  Front Pharmacol       Date:  2022-07-18       Impact factor: 5.988

3.  Comprehensive Analysis of circRNA-miRNA-mRNA Regulatory Network and Novel Potential Biomarkers in Acute Myocardial Infarction.

Authors:  Jiahe Wu; Chenze Li; Zhe Lei; Huanhuan Cai; Yushuang Hu; Yanfang Zhu; Tong Zhang; Haoyan Zhu; Jianlei Cao; Xiaorong Hu
Journal:  Front Cardiovasc Med       Date:  2022-07-07

4.  Evolving scenario of big data and Artificial Intelligence (AI) in drug discovery.

Authors:  Manish Kumar Tripathi; Abhigyan Nath; Tej P Singh; A S Ethayathulla; Punit Kaur
Journal:  Mol Divers       Date:  2021-06-23       Impact factor: 3.364

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.